Answers to the questions practice administrators and healthcare executives ask most.
Most practices that purchase medications directly from manufacturers or authorized distributors and dispense them in-office are eligible. This includes specialty practices (oncology, rheumatology, dermatology, gastroenterology), primary care offices with in-office dispensing programs, urgent care centers, and multi-specialty groups. Eligibility depends on your medication mix, purchasing volume, and existing vendor relationships.
There's no hard minimum, but rebate programs are most impactful for practices dispensing with enough frequency to generate meaningful manufacturer engagement. Our initial assessment will tell you clearly whether your current volume makes a MaveRx engagement worthwhile — and what that potential looks like in dollars.
In many cases, yes. GPO contracts and manufacturer rebate programs are separate mechanisms. Our team reviews your existing purchasing agreements to identify which programs are available to you alongside or independent of your GPO relationships.
Not necessarily. Many rebate programs work with your current distribution channels. Where switching would create meaningfully better economics, we'll surface that as an option — but it's never a requirement to work with MaveRx.
Most practices complete enrollment within 7–14 business days. The timeline depends on how quickly manufacturers process credentialing and whether your purchasing records require any data preparation. Our team manages the entire process and keeps you updated at each stage.
Most enrolled practices receive their first rebate distribution within 30 days of enrollment completion. Actual timing varies by manufacturer payment cycles and your dispensing history.
Very little. MaveRx is designed to integrate with your existing workflow without adding tasks for your team. We pull the data we need, handle manufacturer communications, and deliver clear reports. Your staff doesn't need to learn new software or change how they dispense medications.
We work with your existing EHR, practice management system, or dispensing platform to pull relevant transaction data. Our team handles the technical integration, and we never require you to adopt new software to work with us.
All processes involving protected health information are managed under appropriate Business Associate Agreements (BAAs). We maintain strict data handling protocols and our documentation practices are designed to support your practice's compliance obligations. Our team stays current with relevant federal and state healthcare regulations.
Yes. Manufacturer rebate programs for in-office dispensed medications operate within established legal and regulatory frameworks. MaveRx ensures all programs we manage comply with applicable federal anti-kickback statutes, safe harbor provisions, and state-specific regulations. We provide documentation to support your compliance posture.
Absolutely. Full audit-ready documentation is a standard part of our reporting package. Every claim, every distribution, and every manufacturer communication is documented and available to your practice at any time.
MaveRx operates on a performance-based fee structure — we earn a percentage of the rebates we recover for your practice. There are no upfront fees, no monthly minimums, and no charges for the initial eligibility assessment. If we don't recover rebates, you don't pay.
Our reporting provides full visibility into every enrolled program, every claim submitted, and every rebate distributed. We also conduct periodic program audits to identify new rebate opportunities as your formulary evolves and as manufacturers launch new programs.
Our team manages the dispute process end-to-end. We handle manufacturer communications, provide supporting documentation, and track resolution timelines. You're notified of any disputes and their outcomes, but you don't need to be involved in the process.
A free eligibility review takes 30 minutes and costs nothing. We'll show you the rebate programs you qualify for and estimate your annual recovery potential.